Robert T. McNally, PhD
President and Chief Executive Officer, GeoVax

---

Dr. McNally is President and CEO of GeoVax Labs, Inc., a vaccine company targeting preventive and therapeutic treatment for AIDS. He was previously Co-Founder and CEO of Cell Dynamics LLC.  Cell Dynamics specialized in the recovery and GMP processing of human organs and tissues used for biotech and cellular medical therapies. During the period 1984 to 1998, Dr. McNally was Co-Founder and Sr. Vice President of Clinical Research for CryoLife, Inc., the market leader in transplantable human tissues including cryopreserved heart valves, veins, ligaments and tendons of the knee as well as a manufacturer of protein-derived surgical adhesives. Dr. McNally was with the company from startup through going public on the NASDAQ and NYSE.
Dr. McNally received a Bachelor of Electrical Engineering (B.E.E.) degree from Villanova University, and has a Ph.D. in Biomedical Engineering from the University of Pennsylvania. He has authored numerous patents and publications in the field of transplantable tissues and is a frequent speaker for business development in Georgia and student groups.
Currently, Dr. McNally serves as a member of the advisory boards of the Petit Institute for Bioengineering and Dupree College of Management at the Georgia Institute of Technology. He is an elected fellow of the American Institute for Medical and Biological Engineering, is a past Chairman for the Georgia Biomedical Partnership, a trade association, and is recipient of the 2004 Biomedical Industry Growth Award for the State of Georgia.